APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycomics & Glycobiology

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

Selected research

Market Outlook & Growth Opportunities

Global Glycomics & Glycobiology Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchGlycomics & Glycobiology Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycomics & Glycobiology Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Glycomics & Glycobiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycomics & Glycobiology Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycomics & Glycobiology Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.

Read the full market overview

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.

This report provides an overview of the global Glycomics & Glycobiology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glycomics & Glycobiology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glycomics & Glycobiology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Glycomics & Glycobiology market.

Glycomics & Glycobiology Segment by Company

ThermoFisher Scientific

Danaher

Shimadzu Corporation

ProZyme

Takara Bio, Inc.

Agilent Technologies

Bruker

Promega

Waters Corporation

R&D Systems

New England Biolabs

Merck KGaA

Glycomics & Glycobiology Segment by Type

Instruments

Enzymes

Reagents

Kits

Glycomics & Glycobiology Segment by Application

Drug Discovery & Development

Diagnostics

Others

Glycomics & Glycobiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glycomics & Glycobiology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Glycomics & Glycobiology key companies, revenue, market share, and recent developments.

3. To split the Glycomics & Glycobiology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Glycomics & Glycobiology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glycomics & Glycobiology significant trends, drivers, influence factors in global and regions.

6. To analyze Glycomics & Glycobiology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycomics & Glycobiology industry.

Chapter 3: Detailed analysis of Glycomics & Glycobiology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Glycomics & Glycobiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Glycomics & Glycobiology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glycomics & Glycobiology Industry Trends Table 2. Glycomics & Glycobiology Industry Drivers Table 3. Glycomics & Glycobiology Industry Opportunities and Challenges Table 4. Glycomics & Glycobiology Industry Restraints Table 5. Global Glycomics & Glycobiology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glycomics & Glycobiology Revenue Share by Company (2021-2026) Table 7. Global Glycomics & Glycobiology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Glycomics & Glycobiology Key Company Manufacturing Base & Headquarters Table 9. Global Glycomics & Glycobiology Company, Product Type & Application Table 10. Global Glycomics & Glycobiology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Glycomics & Glycobiology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Instruments Table 15. Significant Companies of Enzymes Table 16. Significant Companies of Reagents Table 17. Significant Companies of Kits Table 18. Global Glycomics & Glycobiology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Glycomics & Glycobiology Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Glycomics & Glycobiology Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Glycomics & Glycobiology Sales Value Share by Type (2021-2026) Table 22. Global Glycomics & Glycobiology Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Drug Discovery & Development Table 24. Significant Companies of Diagnostics Table 25. Significant Companies of Others Table 26. Global Glycomics & Glycobiology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Glycomics & Glycobiology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Glycomics & Glycobiology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Glycomics & Glycobiology Sales Value Share by Application (2021-2026) Table 30. Global Glycomics & Glycobiology Sales Value Share by Application (2027-2032) Table 31. Global Glycomics & Glycobiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Glycomics & Glycobiology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Glycomics & Glycobiology Sales Value Share by Region (2021-2026) Table 34. Global Glycomics & Glycobiology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Glycomics & Glycobiology Sales Value Share by Region (2027-2032) Table 36. Global Glycomics & Glycobiology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Glycomics & Glycobiology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Glycomics & Glycobiology Sales Value Market Share by Country (2021-2026) Table 39. Global Glycomics & Glycobiology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Glycomics & Glycobiology Sales Value Market Share by Country (2027-2032) Table 41. ThermoFisher Scientific Company Information Table 42. ThermoFisher Scientific Business Overview Table 43. ThermoFisher Scientific Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio Table 45. ThermoFisher Scientific Recent Development Table 46. Danaher Company Information Table 47. Danaher Business Overview Table 48. Danaher Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Danaher Glycomics & Glycobiology Product Portfolio Table 50. Danaher Recent Development Table 51. Shimadzu Corporation Company Information Table 52. Shimadzu Corporation Business Overview Table 53. Shimadzu Corporation Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Shimadzu Corporation Glycomics & Glycobiology Product Portfolio Table 55. Shimadzu Corporation Recent Development Table 56. ProZyme Company Information Table 57. ProZyme Business Overview Table 58. ProZyme Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. ProZyme Glycomics & Glycobiology Product Portfolio Table 60. ProZyme Recent Development Table 61. Takara Bio, Inc. Company Information Table 62. Takara Bio, Inc. Business Overview Table 63. Takara Bio, Inc. Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio Table 65. Takara Bio, Inc. Recent Development Table 66. Agilent Technologies Company Information Table 67. Agilent Technologies Business Overview Table 68. Agilent Technologies Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Agilent Technologies Glycomics & Glycobiology Product Portfolio Table 70. Agilent Technologies Recent Development Table 71. Bruker Company Information Table 72. Bruker Business Overview Table 73. Bruker Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bruker Glycomics & Glycobiology Product Portfolio Table 75. Bruker Recent Development Table 76. Promega Company Information Table 77. Promega Business Overview Table 78. Promega Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Promega Glycomics & Glycobiology Product Portfolio Table 80. Promega Recent Development Table 81. Waters Corporation Company Information Table 82. Waters Corporation Business Overview Table 83. Waters Corporation Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Waters Corporation Glycomics & Glycobiology Product Portfolio Table 85. Waters Corporation Recent Development Table 86. R&D Systems Company Information Table 87. R&D Systems Business Overview Table 88. R&D Systems Glycomics & Glycobiology Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. R&D Systems Glycomics & Glycobiology Product Portfolio Table 90. R&D Systems Recent Development Table 91. New England Biolabs Company Information Table 92. New England Biolabs Business Overview Table 93. New England Biolabs Glycomics & Glycobiology Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. New England Biolabs Glycomics & Glycobiology Product Portfolio Table 95. New England Biolabs Recent Development Table 96. Merck KGaA Company Information Table 97. Merck KGaA Business Overview Table 98. Merck KGaA Glycomics & Glycobiology Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Merck KGaA Glycomics & Glycobiology Product Portfolio Table 100. Merck KGaA Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Glycomics & Glycobiology Product Image Figure 2. Global Glycomics & Glycobiology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycomics & Glycobiology Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycomics & Glycobiology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Instruments Image Figure 8. Enzymes Image Figure 9. Reagents Image Figure 10. Kits Image Figure 11. Global Glycomics & Glycobiology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Glycomics & Glycobiology Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Glycomics & Glycobiology Sales Value Share by Type (2021-2032) Figure 14. Drug Discovery & Development Image Figure 15. Diagnostics Image Figure 16. Others Image Figure 17. Global Glycomics & Glycobiology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Glycomics & Glycobiology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Glycomics & Glycobiology Sales Value Share by Application (2021-2032) Figure 20. Global Glycomics & Glycobiology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Glycomics & Glycobiology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Glycomics & Glycobiology Sales Value (2021-2032) & (US$ Million) Figure 23. North America Glycomics & Glycobiology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Glycomics & Glycobiology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Glycomics & Glycobiology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Glycomics & Glycobiology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Glycomics & Glycobiology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Glycomics & Glycobiology Sales Value (2021-2032) & (US$ Million) Figure 29. South America Glycomics & Glycobiology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Glycomics & Glycobiology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Glycomics & Glycobiology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Glycomics & Glycobiology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Instruments
  • Enzymes
  • Reagents
  • Kits
Applications
  • Drug Discovery & Development
  • Diagnostics
  • Others
Companies covered
  • ThermoFisher Scientific
  • Danaher
  • Shimadzu Corporation
  • ProZyme
  • Takara Bio, Inc.
  • Agilent Technologies
  • Bruker
  • Promega
  • Waters Corporation
  • R&D Systems
  • New England Biolabs
  • Merck KGaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glycomics & Glycobiology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glycomics & Glycobiology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Glycomics & Glycobiology Market Dynamics
  1. 2.1 Glycomics & Glycobiology Industry Trends
  2. 2.2 Glycomics & Glycobiology Industry Drivers
  3. 2.3 Glycomics & Glycobiology Industry Opportunities and Challenges
  4. 2.4 Glycomics & Glycobiology Industry Restraints
3 Glycomics & Glycobiology Market by Company
  1. 3.1 Global Glycomics & Glycobiology Company Revenue Ranking in 2025
  2. 3.2 Global Glycomics & Glycobiology Revenue by Company (2021-2026)
  3. 3.3 Global Glycomics & Glycobiology Company Ranking (2024-2026)
  4. 3.4 Global Glycomics & Glycobiology Company Manufacturing Base and Headquarters
  5. 3.5 Global Glycomics & Glycobiology Company Product Type and Application
  6. 3.6 Global Glycomics & Glycobiology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Glycomics & Glycobiology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Glycomics & Glycobiology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Glycomics & Glycobiology Market by Type
  1. 4.1 Glycomics & Glycobiology Type Introduction
  2. 4.1.1 Instruments
  3. 4.1.2 Enzymes
  4. 4.1.3 Reagents
  5. 4.1.4 Kits
  6. 4.2 Global Glycomics & Glycobiology Sales Value by Type
  7. 4.2.1 Global Glycomics & Glycobiology Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Glycomics & Glycobiology Sales Value by Type (2021-2032)
  9. 4.2.3 Global Glycomics & Glycobiology Sales Value Share by Type (2021-2032)
5 Glycomics & Glycobiology Market by Application
  1. 5.1 Glycomics & Glycobiology Application Introduction
  2. 5.1.1 Drug Discovery & Development
  3. 5.1.2 Diagnostics
  4. 5.1.3 Others
  5. 5.2 Global Glycomics & Glycobiology Sales Value by Application
  6. 5.2.1 Global Glycomics & Glycobiology Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glycomics & Glycobiology Sales Value by Application (2021-2032)
  8. 5.2.3 Global Glycomics & Glycobiology Sales Value Share by Application (2021-2032)
6 Glycomics & Glycobiology Regional Value Analysis
  1. 6.1 Global Glycomics & Glycobiology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glycomics & Glycobiology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Glycomics & Glycobiology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Glycomics & Glycobiology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glycomics & Glycobiology Sales Value (2021-2032)
  7. 6.3.2 North America Glycomics & Glycobiology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Glycomics & Glycobiology Sales Value (2021-2032)
  10. 6.4.2 Europe Glycomics & Glycobiology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Glycomics & Glycobiology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Glycomics & Glycobiology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Glycomics & Glycobiology Sales Value (2021-2032)
  16. 6.6.2 South America Glycomics & Glycobiology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Glycomics & Glycobiology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Glycomics & Glycobiology Sales Value Share by Country, 2025 VS 2032
7 Glycomics & Glycobiology Country-level Value Analysis
  1. 7.1 Global Glycomics & Glycobiology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glycomics & Glycobiology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Glycomics & Glycobiology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Glycomics & Glycobiology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Glycomics & Glycobiology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Glycomics & Glycobiology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Glycomics & Glycobiology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ThermoFisher Scientific
  2. 8.1.1 ThermoFisher Scientific Company Information
  3. 8.1.2 ThermoFisher Scientific Business Overview
  4. 8.1.3 ThermoFisher Scientific Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
  6. 8.1.5 ThermoFisher Scientific Recent Developments
  7. 8.2 Danaher
  8. 8.2.1 Danaher Company Information
  9. 8.2.2 Danaher Business Overview
  10. 8.2.3 Danaher Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Danaher Glycomics & Glycobiology Product Portfolio
  12. 8.2.5 Danaher Recent Developments
  13. 8.3 Shimadzu Corporation
  14. 8.3.1 Shimadzu Corporation Company Information
  15. 8.3.2 Shimadzu Corporation Business Overview
  16. 8.3.3 Shimadzu Corporation Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
  18. 8.3.5 Shimadzu Corporation Recent Developments
  19. 8.4 ProZyme
  20. 8.4.1 ProZyme Company Information
  21. 8.4.2 ProZyme Business Overview
  22. 8.4.3 ProZyme Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
  24. 8.4.5 ProZyme Recent Developments
  25. 8.5 Takara Bio, Inc.
  26. 8.5.1 Takara Bio, Inc. Company Information
  27. 8.5.2 Takara Bio, Inc. Business Overview
  28. 8.5.3 Takara Bio, Inc. Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
  30. 8.5.5 Takara Bio, Inc. Recent Developments
  31. 8.6 Agilent Technologies
  32. 8.6.1 Agilent Technologies Company Information
  33. 8.6.2 Agilent Technologies Business Overview
  34. 8.6.3 Agilent Technologies Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
  36. 8.6.5 Agilent Technologies Recent Developments
  37. 8.7 Bruker
  38. 8.7.1 Bruker Company Information
  39. 8.7.2 Bruker Business Overview
  40. 8.7.3 Bruker Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bruker Glycomics & Glycobiology Product Portfolio
  42. 8.7.5 Bruker Recent Developments
  43. 8.8 Promega
  44. 8.8.1 Promega Company Information
  45. 8.8.2 Promega Business Overview
  46. 8.8.3 Promega Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Promega Glycomics & Glycobiology Product Portfolio
  48. 8.8.5 Promega Recent Developments
  49. 8.9 Waters Corporation
  50. 8.9.1 Waters Corporation Company Information
  51. 8.9.2 Waters Corporation Business Overview
  52. 8.9.3 Waters Corporation Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
  54. 8.9.5 Waters Corporation Recent Developments
  55. 8.10 R&D Systems
  56. 8.10.1 R&D Systems Company Information
  57. 8.10.2 R&D Systems Business Overview
  58. 8.10.3 R&D Systems Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
  60. 8.10.5 R&D Systems Recent Developments
  61. 8.11 New England Biolabs
  62. 8.11.1 New England Biolabs Company Information
  63. 8.11.2 New England Biolabs Business Overview
  64. 8.11.3 New England Biolabs Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
  66. 8.11.5 New England Biolabs Recent Developments
  67. 8.12 Merck KGaA
  68. 8.12.1 Merck KGaA Company Information
  69. 8.12.2 Merck KGaA Business Overview
  70. 8.12.3 Merck KGaA Glycomics & Glycobiology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
  72. 8.12.5 Merck KGaA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst